Sarepta Therapeutics, Inc. (SRPT)
18.34
+0.03
(+0.16%)
USD |
NASDAQ |
Feb 10, 14:13
Sarepta Therapeutics Total Liabilities (Quarterly) : 2.173B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.041B |
| Merck & Co., Inc. | -- |
| Pfizer Inc. | -- |
| Keros Therapeutics, Inc. | 39.20M |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.493B |
| Shareholders Equity (Quarterly) | 1.320B |
| Debt to Equity Ratio | 0.947 |
| Current Ratio | 2.950 |
| Net Debt Paydown Yield | 1.19% |